X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs DISHMAN PHARMA - Comparison Results

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE DISHMAN PHARMA SUVEN LIFE/
DISHMAN PHARMA
 
P/E (TTM) x 16.1 25.1 64.2% View Chart
P/BV x 3.8 3.3 114.2% View Chart
Dividend Yield % 0.5 0.7 69.0%  

Financials

 SUVEN LIFE   DISHMAN PHARMA
EQUITY SHARE DATA
    SUVEN LIFE
Mar-17
DISHMAN PHARMA
Mar-16
SUVEN LIFE/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs229374 61.0%   
Low Rs151129 117.2%   
Sales per share (Unadj.) Rs42.7197.8 21.6%  
Earnings per share (Unadj.) Rs6.921.2 32.3%  
Cash flow per share (Unadj.) Rs8.534.7 24.6%  
Dividends per share (Unadj.) Rs1.002.00 50.0%  
Dividend yield (eoy) %0.50.8 66.3%  
Book value per share (Unadj.) Rs52.4179.9 29.1%  
Shares outstanding (eoy) m127.2880.69 157.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.41.3 349.4%   
Avg P/E ratio x27.711.9 233.5%  
P/CF ratio (eoy) x22.27.2 306.9%  
Price / Book Value ratio x3.61.4 258.9%  
Dividend payout %14.69.4 154.8%   
Avg Mkt Cap Rs m24,15820,306 119.0%   
No. of employees `0001.00.8 122.6%   
Total wages/salary Rs m5225,355 9.7%   
Avg. sales/employee Rs Th5,349.719,252.7 27.8%   
Avg. wages/employee Rs Th513.56,459.5 7.9%   
Avg. net profit/employee Rs Th858.12,064.1 41.6%   
INCOME DATA
Net Sales Rs m5,43515,961 34.1%  
Other income Rs m211265 79.5%   
Total revenues Rs m5,64616,226 34.8%   
Gross profit Rs m1,2914,103 31.5%  
Depreciation Rs m2141,091 19.6%   
Interest Rs m57944 6.0%   
Profit before tax Rs m1,2312,334 52.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m359624 57.5%   
Profit after tax Rs m8721,711 51.0%  
Gross profit margin %23.725.7 92.4%  
Effective tax rate %29.226.7 109.1%   
Net profit margin %16.010.7 149.6%  
BALANCE SHEET DATA
Current assets Rs m4,91711,018 44.6%   
Current liabilities Rs m1,1869,517 12.5%   
Net working cap to sales %68.69.4 730.0%  
Current ratio x4.11.2 358.1%  
Inventory Days Days62110 56.2%  
Debtors Days Days3135 88.3%  
Net fixed assets Rs m3,15416,304 19.3%   
Share capital Rs m127161 78.9%   
"Free" reserves Rs m6,54312,907 50.7%   
Net worth Rs m6,67014,516 46.0%   
Long term debt Rs m2594,189 6.2%   
Total assets Rs m8,15729,805 27.4%  
Interest coverage x22.73.5 653.0%   
Debt to equity ratio x00.3 13.5%  
Sales to assets ratio x0.70.5 124.4%   
Return on assets %11.48.9 127.8%  
Return on equity %13.111.8 110.9%  
Return on capital %18.617.5 106.0%  
Exports to sales %024.8 0.0%   
Imports to sales %03.7 0.0%   
Exports (fob) Rs mNA3,956 0.0%   
Imports (cif) Rs mNA596 0.0%   
Fx inflow Rs m4,9964,952 100.9%   
Fx outflow Rs m959697 137.6%   
Net fx Rs m4,0374,255 94.9%   
CASH FLOW
From Operations Rs m1,0882,786 39.1%  
From Investments Rs m-3,107-1,529 203.2%  
From Financial Activity Rs m-300-941 31.9%  
Net Cashflow Rs m-2,319316 -732.8%  

Share Holding

Indian Promoters % 63.4 61.4 103.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 3.7 -  
FIIs % 0.0 12.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 22.1 165.2%  
Shareholders   37,287 46,261 80.6%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   STRIDES SHASUN LTD  CADILA HEALTHCARE  VENUS REMEDIES  DR. DATSONS LABS  WOCKHARDT LTD.  

Compare SUVEN LIFE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Drops 230 Points as Trade War Fears Resurface(12:30 pm)

After opening the day flat, share markets in India witnessed choppy trading activity throughout the day and are presently below the dotted line.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Should You Get out of Small Caps Now... Before the Fall Worsens(Profit Hunter)

Jun 6, 2018

An almost zero-loss strategy that works best when markets correct. Don't let the current volatility overwhelm you. Focus on the fundamentals and long term, and buy stocks where quality meets value.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Jun 19, 2018 02:15 PM

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE 8-QTR ANALYSIS

COMPARE SUVEN LIFE WITH

MARKET STATS